Although it has been shown that a diet high in fat and exposure to certain bacteria can cause atherosclerosis, researchers have for the first time identified distinct gene pathways that are altered by these different stimuli.
Protein One is a development stage biotechnology company. The primary aim of the company is to deliver high quality purified, biologically active proteins to research labs, medical institutions and pharmaceutical companies via a Universal Protein Array (UPA) under development by the company to help companies with their drug discovery program.
Tubon et al., "Nonconserved Surface of the TFIIB Zinc Ribbon Domain Plays a Direct Role in RNA Polymerase II Recruitment", Molecular and Cellular Biology, 24:2863-2874, April 2004
Novartis is diving deeper into the world of gene-based medicine by signing deals with two U.S. biotech companies, giving it access to a powerful new genome editing technology.
Although it has been shown that a diet high in fat and exposure to certain bacteria can cause atherosclerosis, researchers have for the first time identified distinct gene pathways that are altered by these different stimuli.